Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis.
Hashem E El-SeragFasiha KanwalJing NingHannah PowellSaira KhaderiAmit G SingalSumeet AsraniJorge A MarreroChristopher I AmosAaron P ThriftMichelle LusterAbeer AlsarrajLuis OlivaresDarlene SkapuraJenny DengEmad SalemOmar NajjarXian YuHao DuongMichael E ScheurerChristie M BallantyneSalma KaocharPublished in: Gut (2024)
We identified a panel of nine serum biomarkers that is independently associated with developing HCC in cirrhosis and that improved the predictive ability of risk stratification models containing clinical factors.